Seeking Alpha

On Point Advisor's  Instablog

On Point Advisor
11 Followers
1 Following
Send Message
Donald Kay Riker, Ph.D. is President & Founder, On Point Advisors, LLC [www.onpointadvisors.com], a consumer healthcare consultancy he founded in 2007 and Editor-in-Chief, OTC Product News [www.otcproductnews.com]. Dr. Riker was a fellow at New York’s prestigious Rockefeller University,... More
My company:
OTC Product News
My blog:
OTC Product News
  • A Nasal Spray for the Common Cold? [and it's not Zicam] 0 comments
    Jul 17, 2010 5:48 PM | about stocks: MTXX
    Boehringer Ingelheim locks up a promising OTC nasal spray technology to prevent the common cold --- just what Zicam [Matrixx] needed.  Unfortunately the product roll out appears to be entirely outside the US.  n June 28 Boehringer-Ingelheim announced a licensing deal with Marinomed Biotechnologie GmbH for its anti-viral nasal spray marketed in Austria as Coldamaris™.

    Read More



    Disclosure: None
    Themes: Boehringer Ingelheim, Marinomed, Zicam, Matrixx Stocks: MTXX
Back To On Point Advisor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Full index of posts »
Latest Followers

Latest Comments


Most Commented
Posts by Themes
acetaminophen, Ackman, Acquisitions, ACT, adulterated products, Allegra, Alli, antitussives, Arthritis supplements, asthma, Banana Boat, Bayer, Ben Gay, Benadryl, Boehringer Ingelheim, brand equity, Bullfrog, celebrities, Chattem, Ciba, colds, consent decree, consumer healthcare products, Coppertone, cough, CPC, Crest, Dayquil, denture adhesives, destocking, Dexatrim, Dial, Dieting, diphenhydramine, doxepin, drugs, endorsement, Excedrin-PM, FDA, Fixodent, Flector, flu, Glaxo, H1N1, health care, healthcare, Healthcare, Henkel, Hisamitsu, ibuprofen,
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.